Result:Poor· Market: Up
| Metric | Value (₹ Cr) | Q1 FY26 |
|---|---|---|
| Revenue | 0.01 | 70.8% |
| Total Income | 0.02 | 80.2% |
| Expenditure | 0.35 | 43.8% |
| PBT | -0.33 | 105.4% |
| Net Profit | -0.34 | 92.7% |
| OPM | — | |
| NPM | — | |
| EPS | 0.42 | 90.9% |
Micro-cap pharma company with a widening net loss (-0.338 Cr vs -0.175 Cr YoY) on collapsing revenue (-70.9% YoY), reflecting clear deterioration with no adjusted-profit offset.
Informational and educational content only. Not investment advice.